RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment
Tóm tắt
Regulator of G protein signaling 5 (RGS5), as a negative regulator of G protein-coupled receptor (GPCR) signaling, is highly expressed in arterial VSMCs and pericytes, which is involved in VSMC phenotypic heterogeneity and vascular remodeling in tumors. However, its role in normal and tumor vascular remodeling is controversial. RGS5 knockout (Rgs5-KO) mice and RGS5 overexpression or knockdown in VSMCs in vivo by adeno-associated virus type 9 (AAV) carrying RGS5 cDNA or small hairpin RNA (shRNA) targeting RGS5 were used to determine the functional significance of RGS5 in vascular inflammation. RGS5 expression in the triple-negative (TNBCs) and non-triple-negative breast cancers (Non-TNBCs) was determined by immunofluorescent and immunohistochemical staining. The effect of breast cancer cell-conditioned media (BC-CM) on the pro-inflammatory phenotype of VSMCs was measured by phagocytic activity assays, adhesion assay and Western blot. We identified that knockout and VSMC-specific knockdown of RGS5 exacerbated accumulation and pyroptosis of pro-inflammatory VSMCs, resulting in vascular remodeling, which was negated by VSMC-specific RGS5 overexpression. In contrast, in the context of breast cancer tissues, the role of RGS5 was completely disrupted. RGS5 expression was increased in the triple-negative breast cancer (TNBC) tissues and in the tumor blood vessels, accompanied with an extensive vascular network. VSMCs treated with BC-CM displayed enhanced pro-inflammatory phenotype and higher adherent with macrophages. Furthermore, tumor-derived RGS5 could be transferred into VSMCs. These findings suggest that tumor microenvironment shifts the function of RGS5 from anti-inflammation to pro-inflammation and induces the pro-inflammatory phenotype of VSMCs that is favorable for tumor metastasis.
Tài liệu tham khảo
Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131.
Adams LD, Geary RL, McManus B, Schwartz SM. A comparison of aorta and vena cava medial message expression by cdna array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res. 2000;87(7):623–31.
Berger M, Bergers G, Arnold B, Hammerling GJ, Ganss R. Regulator of g-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 2005;105(3):1094–101.
Grayson TH, Ohms SJ, Brackenbury TD, Meaney KR, Peng K, Pittelkow YE, et al. Vascular microarray profiling in two models of hypertension identifies caveolin-1, rgs2 and rgs5 as antihypertensive targets. BMC Genomics. 2007;8:404.
Holobotovskyy V, Manzur M, Tare M, Burchell J, Bolitho E, Viola H, et al. Regulator of g-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling. Circ Res. 2013;112(5):781–91.
Zhang H, Gu S, Al-Sabeq B, Wang S, He J, Tam A, et al. Origin-specific epigenetic program correlates with vascular bed-specific differences in rgs5 expression. Faseb J. 2012;26(1):181–91.
Hamzah J, Jugold M, Kiessling F, Rigby P, Manzur M, Marti HH, et al. Vascular normalization in rgs5-deficient tumors promotes immune destruction. Nature. 2008;453(7193):410–4.
Hong K, Li M, Nourian Z, Meininger GA, Hill MA. Angiotensin ii type 1 receptor mechanoactivation involves rgs5 (regulator of g protein signaling 5) in skeletal muscle arteries: impaired trafficking of rgs5 in hypertension. Hypertension. 2017;70(6):1264–72.
Arnold C, Demirel E, Feldner A, Genove G, Zhang H, Sticht C, et al. Hypertension-evoked rhoa activity in vascular smooth muscle cells requires rgs5. Faseb J. 2018;32(4):2021–35.
Li Y, Yan H, Guo J, Han Y, Zhang C, Liu X, et al. Down-regulated rgs5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease. Cardiovasc Res. 2021;117(1):240–55.
Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, et al. Ppardelta-mediated anti-inflammatory mechanisms inhibit angiotensin ii-accelerated atherosclerosis. Proc Natl Acad Sci U S A. 2008;105(11):4277–82.
Cheng WL, Wang PX, Wang T, Zhang Y, Du C, Li H, et al. Regulator of g-protein signaling 5 protects against atherosclerosis in apolipoprotein e-deficient mice. Br J Pharmacol. 2015;172(23):5676–89.
Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH. Pericyte-specific expression of rgs5: implications for pdgf and edg receptor signaling during vascular maturation. Faseb J. 2003;17(3):440–2.
Daniel JM, Prock A, Dutzmann J, Sonnenschein K, Thum T, Bauersachs J, et al. Regulator of g-protein signaling 5 prevents smooth muscle cell proliferation and attenuates neointima formation. Arterioscler Thromb Vasc Biol. 2016;36(2):317–27.
Gao YK, Guo RJ, Xu X, Huang XF, Song Y, Zhang DD, et al. A regulator of g protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease. PLoS ONE. 2022;17(3): e265132.
Manzur M, Hamzah J, Ganss R. Modulation of g protein signaling normalizes tumor vessels. Cancer Res. 2009;69(2):396–9.
Xu X, Zhang DD, Kong P, Gao YK, Huang XF, Song Y, et al. Sox10 escalates vascular inflammation by mediating vascular smooth muscle cell transdifferentiation and pyroptosis in neointimal hyperplasia. Cell Rep. 2023;42(8): 112869.
Engelhardt B, Ransohoff RM. Capture, crawl, cross: the t cell code to breach the blood-brain barriers. Trends Immunol. 2012;33(12):579–89.
Zhang JC, Kim S, Helmke BP, Yu WW, Du KL, Lu MM, et al. Analysis of sm22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol. 2001;21(4):1336–44.
Feil S, Hofmann F, Feil R. Sm22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res. 2004;94(7):863–5.
Zhang DD, Song Y, Kong P, Xu X, Gao YK, Dou YQ, et al. Smooth muscle 22 alpha protein inhibits vsmc foam cell formation by supporting normal lxralpha signaling, ameliorating atherosclerosis. Cell Death Dis. 2021;12(11):982.
Chen R, Zhang F, Song L, Shu Y, Lin Y, Dong L, et al. Transcriptome profiling reveals that the sm22alpha-regulated molecular pathways contribute to vascular pathology. J Mol Cell Cardiol. 2014;72:263–72.
Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 2007;15(3):100–8.
Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Vascular remodeling in cancer. Oncogene. 2014;33(27):3496–505.
Rieger H, Welter M. Integrative models of vascular remodeling during tumor growth. Wiley Interdiscip Rev Syst Biol Med. 2015;7(3):113–29.
Ali HR, Jackson HW, Zanotelli V, Danenberg E, Fischer JR, Bardwell H, et al. Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer. Nat Cancer. 2020;1(2):163–75.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.
Hu M, Chen X, Zhang J, Wang D, Fang X, Wang X, et al. Over-expression of regulator of g protein signaling 5 promotes tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells. J Surg Oncol. 2013;108(3):192–6.
Wang Q, Liu M, Mullah B, Siderovski DP, Neubig RR. Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J Biol Chem. 2002;277(28):24949–58.
Silini A, Ghilardi C, Figini S, Sangalli F, Fruscio R, Dahse R, et al. Regulator of g-protein signaling 5 (rgs5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor’s proangiogenic microenvironment. Cell Mol Life Sci. 2012;69(7):1167–78.
Aguilar-Pineda JA, Vera-Lopez KJ, Shrivastava P, Chavez-Fumagalli MA, Nieto-Montesinos R, Alvarez-Fernandez KL, et al. Vascular smooth muscle cell dysfunction contributes to neuroinflammation and tau hyperphosphorylation in alzheimer disease. Iscience. 2021;24(9): 102993.
Shen J, Yang M, Ju D, Jiang H, Zheng JP, Xu Z, et al. Disruption of sm22 promotes inflammation after artery injury via nuclear factor kappab activation. Circ Res. 2010;106(8):1351–62.